Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Journal:
Current Drug Targets
Volume:
12
Page:
1056-1081
Author(s):
Karolina Blajecka, Anna Borgstrom and Alexandre Arcaro
Biology of Cox-2: An Application in Cancer Therapeutics
Journal:
Current Drug Targets
Volume:
12
Page:
1082-1093
Author(s):
Zakir Khan, Noor Khan, Ram P. Tiwari, Nand K. Sah, GBKS Prasad and Prakash S. Bisen
Removing Protein Aggregates: The Role of Proteolysis in Neurodegeneration
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2459-2476
Author(s):
D. A.T. Nijholt, L. De Kimpe, H. L. Elfrink, J. J.M. Hoozemans and W. Scheper
Posttranslational Modifications as Versatile Regulators of Parkin Function
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2477-2485
Author(s):
E. Rubio de la Torre, P. Gomez-Suaga, M. Martínez-Salvador and S. Hilfiker
Mechanisms of Resistance to Photodynamic Therapy
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2486-2515
Author(s):
A. Casas, G. Di Venosa, T. Hasan and Al. Batlle
Members of CRF Family and their Receptors: From Past to Future
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2583-2600
Author(s):
G. Liapakis, M. Venihaki, A. Margioris, D. Grigoriadis and K. Gkountelias
Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2686-2714
Author(s):
S. J. Shuttleworth, F. A. Silva, A. R.L. Cecil, C. D. Tomassi, T. J. Hill, F. I. Raynaud, P. A. Clarke and P. Workman
mTOR Inhibitors: Facing New Challenges Ahead
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2743-2762
Author(s):
I. Mavrommati and T. Maffucci
Serotonin Receptors of Type 6 (5-HT6): What can we Expect from them?
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2783-2790
Author(s):
D. Marazziti, S. Baroni, M. Catena Dell'Osso, F. Bordi and F. Borsini
Bioinformatics Approach to BDNF and BDNF-Related Disorders
Journal:
Current Neuropharmacology
Volume:
9
Page:
318-329
Author(s):
Alvaro Machado Dias